2,393
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Emerging drug targets in amyotrophic lateral sclerosis

, PhD (Senior Director of Target Advancement) & , PhD (Senior Vice President)
Pages 5-20 | Published online: 17 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francisco Espejo-Porras, Javier Fernández-Ruiz & Eva de Lago. (2018) Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:5-6, pages 377-386.
Read now

Articles from other publishers (2)

Eva de Lago, Miguel Moreno-Martet, Francisco Espejo-Porras & Javier Fernández-Ruiz. 2015. Cannabinoids in Neurologic and Mental Disease. Cannabinoids in Neurologic and Mental Disease 99 123 .
Carolina Allers, Janet A Jones, Gabriel P Lasala & José J Minguell. (2014) Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?. Regenerative Medicine 9:5, pages 637-647.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.